カテゴリ： MarketLine, ドイツ, 企業調査

Boehringer Ingelheim GmbH：企業の戦略・SWOT・財務分析

◆英語タイトル：Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4136
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：57
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Boehringer Ingelheim GmbH – Strategy, SWOT and Corporate Finance Report
Summary

Boehringer Ingelheim GmbH – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Boehringer Ingelheim GmbH (Boehringer or ‘the group’) is a privately-held pharmaceuticals and animal health business group. The group offers a wide range of prescription medicines, biopharmaceutical products and animal healthcare products. It also conducts developments, research and manufacture of pharmaceuticals. The company’s products find application in the treatment of respiratory diseases, central nervous system disorders, metabolic disorders, cardiovascular diseases, urological and viral conditions, cancer among others. It operates facilities for manufacturing pharmaceutical products, medical products and chemical active substances. It operates in Europe, the Americas, Asia, Australia and Africa. Boehringer is headquartered in Ingelheim, Rheinland-Pfalz, Germany.

Scope

- Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis
- An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments
- Intelligence on Boehringer Ingelheim GmbH’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Boehringer Ingelheim GmbH’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Boehringer Ingelheim GmbH: Company Overview
Boehringer Ingelheim GmbH: Overview and Key Facts
Boehringer Ingelheim GmbH: Overview
Boehringer Ingelheim GmbH: Key Facts
Boehringer Ingelheim GmbH: Key Employees
Boehringer Ingelheim GmbH: Key Employee Biographies
Boehringer Ingelheim GmbH: Major Products and Services
Boehringer Ingelheim GmbH: Company History
Boehringer Ingelheim GmbH: Management Statement
Boehringer Ingelheim GmbH: Locations and Subsidiaries
Boehringer Ingelheim GmbH: Key Competitors
Boehringer Ingelheim GmbH: Company Analysis
Boehringer Ingelheim GmbH: Business Description
Boehringer Ingelheim GmbH: SWOT Analysis
Boehringer Ingelheim GmbH: SWOT Overview
Boehringer Ingelheim GmbH: Strengths
Boehringer Ingelheim GmbH: Weaknesses
Boehringer Ingelheim GmbH: Opportunities
Boehringer Ingelheim GmbH: Threats
Boehringer Ingelheim GmbH: Corporate Financial Deals Activity
Boehringer Ingelheim GmbH: Financial Deals Overview
Boehringer Ingelheim GmbH: Targets and Partners
Boehringer Ingelheim GmbH: Top Deals 2016 – 2020YTD*
Boehringer Ingelheim GmbH: Advisors
Boehringer Ingelheim GmbH: Top Legal Advisors
Boehringer Ingelheim GmbH: Top Financial Advisors
Boehringer Ingelheim GmbH: Mergers and Acquisitions
Boehringer Ingelheim GmbH: Partnership
Boehringer Ingelheim GmbH: Divestments
Boehringer Ingelheim GmbH: Recent Developments
Boehringer Ingelheim GmbH: News and Events Summary
Boehringer Ingelheim GmbH: Contracts
Boehringer Ingelheim GmbH: Corporate Governance
Boehringer Ingelheim GmbH: Financial Deals
Boehringer Ingelheim GmbH: Market Developments
Boehringer Ingelheim GmbH: Red Flags/DistressSignals
Boehringer Ingelheim GmbH: Regulatory and Legal Events
Boehringer Ingelheim GmbH: Research & Development
Boehringer Ingelheim GmbH: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Boehringer Ingelheim GmbH: Key Facts
Table 2: Boehringer Ingelheim GmbH: Key Employees
Table 3: Boehringer Ingelheim GmbH: Company History
Table 4: Boehringer Ingelheim GmbH: Locations and Subsidiaries
Table 5: Boehringer Ingelheim GmbH: Key Competitors
Table 6: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Table 8: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Table 10: Boehringer Ingelheim GmbH: Targets and Partners
Table 11: Boehringer Ingelheim GmbH: Top Deals 2016 - 2020YTD*
Table 12: Boehringer Ingelheim GmbH: Legal Advisor Ranking by Value (US$m)
Table 13: Boehringer Ingelheim GmbH: Financial Advisor Ranking by Value (US$m)
Table 14: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Boehringer Ingelheim GmbH: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Boehringer Ingelheim GmbH: Divestments by Geography (2016 - YTD*2020)
Table 20: Boehringer Ingelheim GmbH: News and Events Summary
Table 21: Boehringer Ingelheim GmbH: Contracts
Table 22: Boehringer Ingelheim GmbH: Corporate Governance
Table 23: Boehringer Ingelheim GmbH: Financial Deals
Table 24: Boehringer Ingelheim GmbH: Market Developments
Table 25: Boehringer Ingelheim GmbH: Red Flags/DistressSignals
Table 26: Boehringer Ingelheim GmbH: Regulatory and Legal Events
Table 27: Boehringer Ingelheim GmbH: Research & Development
Table 28: Boehringer Ingelheim GmbH: Strategy and Operations

★海外企業調査レポート[Boehringer Ingelheim GmbH：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Mitsubishi Ufj Financial Group Inc
    Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Ufj Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • NeuroLogica Corp：医療機器：M&Aディール及び事業提携情報
    Summary NeuroLogica Corp (NeuroLogica), a subsidiary of Samsung Electronics America Inc is a medical device company that develops, manufactures and markets medical imaging equipment. The company offers digital radiography systems for hospitals and imaging centers, portable CT imaging systems, and ul …
  • Poslovni sistem Mercator, d.d.：企業の戦略・SWOT・財務情報
    Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report Summary Poslovni sistem Mercator, d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Seven Generations Energy Ltd (VII)：企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Imricor Medical Systems Inc：医療機器：M&Aディール及び事業提携情報
    Summary Imricor Medical Systems Inc (Imricor) is a medical device company that offers MRI equipment. The company provides products such as cardiac ablation systems, vision MR EP ablation catheter and horizon MR EP recording system. Its vision MR EP ablation catheter is used to operate in a MRI room; …
  • Premaitha Health Plc (NIPT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Defense Commissary Agency：企業の戦略的SWOT分析
    Defense Commissary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Town Health International Medical Group Ltd (3886)：企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • Randox Laboratories Ltd-医療機器分野：企業M&A・提携分析
    Summary Randox Laboratories Ltd (Randox) is a clinical diagnostic company that manufactures and provides clinical diagnostic solutions to laboratories. The company’s products include biochip analyzers, biochip immunoassays, clinical chemistry analyzers and diagnostic reagents among others. It offers …
  • Precision System Science Co Ltd (7707)-医療機器分野：企業M&A・提携分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company’s products include automated nucleic acid isolation system, large sample volume nucleic acid extraction sy …
  • Abbott Diabetes Care Inc：医療機器：M&Aディール及び事業提携情報
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • Hokka Hokka：企業の戦略・SWOT・財務分析
    Hokka Hokka - Strategy, SWOT and Corporate Finance Report Summary Hokka Hokka - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd：企業の戦略的SWOT分析
    The Petroleum Oil and Gas Corporation of South Africa (SOC) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employee …
  • Cellestia Biotech AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • Nanomerics Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Commercial Bank Of Kuwait Sak：企業の戦略・SWOT・財務分析
    Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank Of Kuwait Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Reliance Steel & Aluminum Co：企業の戦略・SWOT・財務分析
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Eurazeo SA：企業のM&A・事業提携・投資動向
    Eurazeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurazeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • 4D Molecular Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) is a gene therapy company that deliver genes to specific cells in the body to eradicate rare and large market diseases. The company discovers and develops targeted and proprietary AAV gene therapy vectors and therapeutic products. It …
  • Airbus SAS：企業のM&A・事業提携・投資動向
    Airbus SAS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Airbus SAS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆